Proctor and Gamble 2003 Annual Report Download - page 16

Download and view the complete annual report

Please find page 16 of the 2003 Proctor and Gamble annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 60

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60

Net Sales
(in billions of dollars)
4.4
5.8
5.0
20032001 2002
Net Earnings
(in millions of dollars)
390
706
521
20032001 2002
Prilosec OTC
Prilosec, the world’s #1 selling drug
in its class, is now available over the
counter to treat frequent heartburn.
Actonel
Actonel delivered $650 million in
global alliance sales worldwide.
Health Care is the
Company’s fastest growing
business, with innovations
over the last three years
representing more than
$1 billion in new sales. Key
brands include Crest, Iams,
Eukanuba, Vicks, Actonel,
Asacol, Scope, Pepto-Bismol
and ThermaCare.
• Health Care net sales grew
16% to $5.8 billion.
• Health Care net earnings
grew 35% to $706 million.
Health Care